Pingyangmycin as First-Line Treatment for Low-Flow Orbital or Periorbital Venous Malformations

JAMA Ophthalmology - United States
doi 10.1001/jamaophthalmol.2013.8229
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Treatment of Periorbital and Palpebral Arteriovenous Malformations

Advances in Wound Care
Critical CareEmergency MedicineIntensive Care Medicine
2019English

Outpatient Use of Low Molecular Weight Heparin Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer

Oncologist
Cancer ResearchMedicineOncology
2012English

Orbital Floor Fracture With Periorbital Haematoma

BMJ Case Reports
Medicine
2019English

Pembrolizumab as First-Line Treatment for Metastatic Uveal Melanoma

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Metformin as First-Line Treatment for Type 2 Diabetes

The Lancet
Medicine
2018English

Orbital Arteriovenous Malformations

Archives of Ophthalmology
2008English

Interventional Radiology for Venous Malformations

The Japanese Journal of Phlebology
2019English

Mucocutaneous Venous Malformations

2020English

Endovascular Treatment as First Line Approach for Infrarenal Aortic Occlusive Disease

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy